• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    India Porcine Vaccines Market

    ID: MRFR/Pharma/49056-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    India Porcine Vaccines Market Research Report By Type (Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines), By Disease Indication (PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD), Others) and By End-user (Veterinary Hospitals, Hog Production Farm)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    India Porcine Vaccines Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    India Porcine Vaccines Market Summary

    The India Porcine Vaccines market is projected to grow significantly from 89.5 million USD in 2024 to 213 million USD by 2035.

    Key Market Trends & Highlights

    India Porcine Vaccines Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate (CAGR) of 8.2 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 213 million USD, indicating robust growth potential.
    • In 2024, the market is valued at 89.5 million USD, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced vaccination technologies due to increasing awareness of animal health is a major market driver.

    Market Size & Forecast

    2024 Market Size 89.5 (USD Million)
    2035 Market Size 213 (USD Million)
    CAGR (2025-2035) 8.2%

    Major Players

    Indian Immunologicals, Ceva Animal Health, Virbac, Neogen Corporation, Heska Corporation, Zoetis, Vetoquinol, Petersime, Biovet, Elanco, Zydus Cadila, Merck Animal Health, Hester Biosciences, Boehringer Ingelheim, Karnataka Veterinary Biologicals Corporation

    Market Segment Insights

    Porcine Vaccines Market Type Insights

    The India Porcine Vaccines Market exhibits a diverse range of types that play vital roles in safeguarding swine health and enhancing productivity. The major type categories include Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, and DNA vaccines. Inactivated vaccines are crucial for providing immunity without the risk of causing disease, making them a favored choice among veterinarians. These vaccines are essential in managing endemic diseases in pigs, thereby protecting the health of herds across India.

    Live attenuated vaccines carry a live but weakened pathogen, which tends to yield strong immune responses, making them effective for preventive measures against various viral infections in swine. Toxoid vaccines offer significant benefits by targeting bacterial toxins rather than the bacteria themselves, thus proving vital in controlling diseases that produce harmful toxins.

    Recombinant vaccines, on the other hand, utilize biotechnology to create vaccine components, fostering a more efficient immune response and broadening their application in enhancing swine health. Conjugate vaccines are noteworthy as they combine polysaccharides with proteins to enhance immunity, especially in cases where traditional vaccines may be less effective.

    DNA vaccines are emerging as an innovative technology that leverages genetic material to provoke a protective immune response; their adaptability and potential for rapid development make them an important facet of future vaccine strategies. The overall segmentation of the India Porcine Vaccines Market reveals substantial opportunities for growth as swine farming continues to be a significant sector within the Indian agricultural landscape, where efficiency, health management, and disease prevention are crucial.

    With advancements in veterinary biotechnology and a growing understanding of swine diseases, the market is likely to witness innovations and a shift towards more specialized vaccines tailored to meet the needs of Indian swine farmers. The increasing focus on livestock health and biosecurity practices drives the demand for these vaccines, as they play a fundamental role in improving the overall productivity and profitability of the pork industry. Understanding these dynamics within the Type segment is vital for stakeholders aiming to navigate the evolving landscape of the India Porcine Vaccines Market.

    Porcine Vaccines Market Disease Indication Insights

    The Disease Indication segment within the India Porcine Vaccines Market is a crucial aspect of the industry, focusing on various infectious diseases affecting swine populations. With the substantial increase in pig farming in India, there has been a growing emphasis on vaccines that target Porcine Epidemic Diarrhea (PED) and Porcine Reproductive and Respiratory Syndrome (PRRS), both of which have significant impacts on herd health and productivity.

    The prevalence of Swine influenza remains a concern due to its potential to cause severe outbreaks, while Aujeszky's disease (AD) and Porcine Circovirus Associated Disease (PCVAD) also contribute significantly to economic losses among farmers. The increasing awareness of biosecurity measures, coupled with advancements in vaccine technology, is driving the demand for effective solutions in the Porcine market.

    The market is witnessing a trend toward the development of multi-valent vaccines to combat various pathogens simultaneously, reflecting the evolving needs of the livestock sector. As India strives to enhance its livestock health standards and productivity, addressing these disease indications will play a vital role in securing the future of the country's pork industry.

    Porcine Vaccines Market End-user Insights

    The End-user segment of the India Porcine Vaccines Market plays a critical role in healthcare for swine, with Veterinary Hospitals and Hog Production Farms serving as key players in this landscape. Veterinary Hospitals are essential for administering vaccines and ensuring the health and productivity of pigs, acting as a primary point of contact for both preventive and treatment measures.

    They contribute significantly to maintaining animal welfare and reducing disease outbreaks, which is crucial in a densely populated country like India, where the demand for pork is rising. On the other hand, Hog Production Farms dominate the industry, forming the backbone of pork supply and focusing on biosecurity and vaccination programs to enhance herd immunity and minimize losses due to diseases.

    These farms are increasingly adopting advanced vaccination techniques and strategies to improve production efficiency and overall livestock health. The rising focus on antibiotic-free meat production is also driving the demand for effective vaccinal solutions in this segment. The interplay between these End-users significantly influences the market dynamics, highlighting the importance of both Veterinary Hospitals and Hog Production Farms in the overall landscape of the India Porcine Vaccines Market.

    Get more detailed insights about India Porcine Vaccines Market Research Report - Forecast to 2035

    Key Players and Competitive Insights

    The India Porcine Vaccines Market is characterized by a competitive landscape that includes both domestic and international players vying for significant market share. This market is driven by rising awareness about animal health, increased production of pork, and stringent regulations regarding animal vaccination to prevent diseases among porcine populations. The competitive dynamics are shaped by factors like technological advancements in vaccine development, pricing strategies, and strong distribution networks. Understanding the positioning of key players in this market is crucial for identifying trends and forecasting growth opportunities.

    It is notable that market participants are increasingly focusing on research and development to introduce novel vaccine solutions that address emerging health challenges among pigs. Indian Immunologicals has established a strong foothold in the India Porcine Vaccines Market, primarily through its innovative vaccine formulations and commitment to quality. The company's strengths lie in its production capabilities and extensive distribution network across the country, enabling it to cater to various segments of the market effectively.

    Indian Immunologicals has a reputation for producing high-quality porcine vaccines that meet both domestic and international standards, thereby gaining the trust of veterinarians and farmers alike. Furthermore, their customer-centric approach and focus on education about the importance of vaccination in swine health contribute to enhancing their market presence. The company’s ability to adapt to changing market needs further solidifies its competitive edge in the Indian landscape.

    Ceva Animal Health is a prominent player in the India Porcine Vaccines Market, recognized for its comprehensive range of products and services tailored specifically to the needs of the swine industry. The company's key offerings include various vaccines that target prevalent diseases in pigs, supported by their strong research and development initiatives aimed at delivering effective health solutions.

    Ceva's well-established market presence in India is bolstered by strategic partnerships and collaborations that enhance its distribution capabilities, ensuring that stakeholders have access to essential veterinary products. Their commitment to excellence is reflected in their continuous investment in innovation and technology, which positions Ceva as a leader in providing holistic animal health solutions. The company’s mergers and acquisitions have also expanded its product portfolio and geographical reach, allowing it to better serve the burgeoning porcine sector in India.

    Key Companies in the India Porcine Vaccines Market market include

    Industry Developments

    Recent developments in the India Porcine Vaccines Market have emphasized advancements in disease prevention and control, with several companies active in this space. Indian Immunologicals continues to innovate in porcine health solutions, while Ceva Animal Health and Virbac have introduced new vaccine formulations to combat viral diseases like Porcine Reproductive and Respiratory Syndrome (PRRS).

    The market is experiencing significant growth due to increasing pig farming and heightened awareness of veterinary health. Notably, Zydus Cadila expanded its portfolio with the launch of new vaccines addressing specific pig diseases in July 2023, further enhancing its market presence.

    Additionally, the regional demand has prompted companies like Zoetis and Elanco to invest in Research and Development for more effective vaccines. There have been no significant mergers or acquisitions reported in the past few months among key companies like Heska Corporation and Boehringer Ingelheim. The economic valuation of the porcine vaccine sector in India has been positively impacted, driven by a rising trend in livestock vaccination, reinforcing the importance of maintaining animal health standards in the face of growing meat consumption. The Indian government's initiatives to promote livestock health are also influencing market dynamics.

    Market Segmentation

    Porcine Vaccines Market Type Outlook

    • Inactivated vaccines
    • Live attenuated vaccines
    • Toxoid vaccines
    • Recombinant vaccines
    • Conjugate vaccines
    • DNA vaccines

    Porcine Vaccines Market End-user Outlook

    • Veterinary Hospitals
    • Hog Production Farm

    Porcine Vaccines Market Disease Indication Outlook

    • PED (Porcine Epidemic Diarrhea)
    • PRRS (Porcine Reproductive & Respiratory Syndrome)
    • Swine influenza
    • Aujeszky's disease (AD)
    • Porcine Circovirus Associated Disease (PCVAD)
    • Others

    Report Scope

     
    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 89.5(USD Million)
    MARKET SIZE 2024 96.0(USD Million)
    MARKET SIZE 2035 213.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.514% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Indian Immunologicals, Ceva Animal Health, Virbac, Neogen Corporation, Heska Corporation, Zoetis, Vetoquinol, Petersime, Biovet, Elanco, Zydus Cadila, Merck Animal Health, Hester Biosciences, Boehringer Ingelheim, Karnataka Veterinary Biologicals Corporation
    SEGMENTS COVERED Type, Disease Indication, End-user
    KEY MARKET OPPORTUNITIES Increasing pig farming regulations, Growing demand for biosecurity measures, Rise in consumer health consciousness, Advancements in vaccine technology, Expansion of distribution networks
    KEY MARKET DYNAMICS increasing pork consumption, rise in swine diseases, government health initiatives, adoption of advanced vaccination technologies, growth of animal husbandry sector
    COUNTRIES COVERED India

    FAQs

    What is the expected market size of the India Porcine Vaccines Market in 2024?

    The India Porcine Vaccines Market is expected to be valued at 96.0 million USD in 2024.

    What is the projected market size for the India Porcine Vaccines Market by 2035?

    By 2035, the India Porcine Vaccines Market is projected to reach a value of 213.0 million USD.

    What is the expected CAGR for the India Porcine Vaccines Market during the forecast period of 2025 to 2035?

    The expected CAGR for the India Porcine Vaccines Market from 2025 to 2035 is 7.514%.

    Which type of porcine vaccine is expected to hold the largest market share in 2024?

    In 2024, inactivated vaccines are expected to hold the largest market share valued at 34.0 million USD.

    What is the anticipated market value for live attenuated vaccines in the India Porcine Vaccines Market by 2035?

    The market value for live attenuated vaccines is anticipated to reach 55.0 million USD by 2035.

    Who are the major players in the India Porcine Vaccines Market?

    Key players in the market include Indian Immunologicals, Ceva Animal Health, Virbac, and Zoetis among others.

    What are the expected trends driving growth in the India Porcine Vaccines Market from 2025 to 2035?

    Trends driving growth include rising pig farming, increasing awareness of animal health, and advancements in vaccine technology.

    What will be the market size of toxoid vaccines in the India Porcine Vaccines Market by 2035?

    The market size of toxoid vaccines is expected to reach 35.0 million USD by 2035.

    Which vaccine type is projected to have the highest growth rate in the India Porcine Vaccines Market?

    Recombinant vaccines are projected to exhibit a significant growth rate, reaching 30.0 million USD by 2035.

    How do regional trends impact the India Porcine Vaccines Market growth?

    Regional trends affect growth through variations in livestock practices, governmental policies, and disease outbreaks in different areas.

    India Porcine Vaccines Market Research Report - Forecast to 2035 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials